Concepedia

Hamna Shahnawaz

HS

5

Publications

545

Citations

5

H-Index

2021

Active since

Affiliations

University of Pennsylvania(Current)

Acuitas Therapeutics (Canada)

Translational Therapeutics (United States)

Hamna Shahnawaz is an author at University of Pennsylvania specializing in chronic inflammation, inflammation, and allergy.

ORCID

Top concepts

Publications per year

2021–2025

5

Publications

5

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

István Tombácz, Dorottya Laczkó, Hamna Shahnawaz et al. · Molecular Therapy · 2021 · 239 citations · Full text

One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA

Dapeng Zhang, Elena N. Atochina‐Vasserman, Devendra S. Maurya et al. · Journal of the American Chemical Society · 2021 · 146 citations

Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)

Hamideh Parhiz, Priyal Patel, Tyler E. Papp et al. · Journal of Controlled Release · 2021 · 126 citations · Full text

, , +7

Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system

Hamideh Parhiz, Vladimir V. Shuvaev, Qin Li et al. · Molecular Therapy — Nucleic Acids · 2024 · 17 citations · Full text

CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery

Tyler E. Papp, Jianhao Zeng, Hamna Shahnawaz et al. · Molecular Therapy · 2025 · 17 citations · Full text

Rows per page

1–5 of 5